CLINICAL_TRIALS
trial_result
· 2013-05-27
Clinical Trial Update: Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study) [Phase 3]
Summary
Phase 3 DOSE-AHF trial update examining the optimal dose and duration of intravenous diuretic therapy in patients with acute heart failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2013-05-27